Redox signalling versus oxidative damage: balancing physiological and pathological ROS Cells continuously generate ROS, yet most of the time these species act as context-limited signals rather than indiscriminate toxins
Supporting this extended regeneration phase with compounds like BPC 157 peptide may result in more complete, resilient repairs that are less likely to re-injure
Additionally, cembrene diterpenoids were found to significantly inhibit the phosphorylation of related proteins within the MAPK pathway in skin lesions
Early Phase Rehabilitation (Weeks 1-2) During the initial treatment phase, focus on protecting the injury while maintaining gentle movement
Constipation, diarrhea, and general digestive discomfort can make the weight loss journey more difficult than necessary

Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety
